Entera Bio
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $42 | $82 |
Gross Profit | -8 | -7 | 0 | 0 |
EBITDA | -3,192 | -2,661 | -2,555 | -2,326 |
EBIT | -3,200 | -2,668 | -2,563 | -2,337 |
Net Income | -3,200 | -2,656 | -2,567 | -2,358 |
Net Change In Cash | 0 | 0 | 42 | 82 |
Free Cash Flow | -2,786 | -1,674 | -1,412 | -1,470 |
Cash | 8,574 | 10,858 | 12,573 | 8,660 |
Basic Shares | 47,089 | 46,836 | 43,377 | 37,647 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $181 | $14 | $134 | $571 |
Gross Profit | 9 | -56 | 33 | 198 |
EBITDA | -9,539 | -8,804 | -12,953 | -12,164 |
EBIT | -9,585 | -8,860 | -13,017 | -12,217 |
Net Income | -9,541 | -8,889 | -13,071 | -12,187 |
Net Change In Cash | 181 | 14 | 134 | 571 |
Free Cash Flow | -6,821 | -7,327 | -12,546 | -9,080 |
Cash | 8,660 | 11,019 | 12,309 | 24,892 |
Basic Shares | 37,650 | 29,007 | 28,808 | 26,133 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.07 |
2025-06-30 | -$0.06 |
2025-03-31 | -$0.06 |
